NIH and partners host meeting to discuss the future of spinal cord injury research

NewsGuard 100/100 Score

Research and patient community to discuss challenges and potential breakthroughs  

WHAT:

The National Institutes of Health (NIH) and its partners will host a meeting of researchers, clinicians, patients and patient advocates to discuss spinal cord injury (SCI) research and to chart a course of future studies. The two-day meeting will focus on three important timepoints for spinal cord injury: acute, sub-acute, and chronic. Other sessions will discuss the latest pre-clinical, clinical, and technological research relating to SCI. Overall, the meeting aims to discuss how to overcome barriers and improve collaboration.

Michael Boninger, M.D., from the McGowan Institute for Regenerative Medicine at the University of Pittsburgh will give the keynote presentation. Dr. Boninger will draw on his experience as a physical medicine and rehabilitation physician and a researcher that crosses the boundaries between laboratory and clinic to set the stage for a discussion of what the future could hold for persons with spinal cord injury.

WHEN:

February 12-13, 2019, NIH Natcher Conference Center, Bethesda, Maryland

In-person registration for this event has closed; however, the event will be streamed via webcast at https://videocast.nih.gov/.

For more information about the meeting, including a complete agenda and list of speakers, please visit https://meetings.ninds.nih.gov/meetings/SCI2020.

WHO:

The following NIH event organizers will be available for interviews:

  • Lyn Jakeman, Ph.D., Director of Neuroscience, NIH’s National Institute of Neurological Disorders and Stroke (NINDS)
  • Alison Cernich, Ph.D., Director, National Center for Medical Rehabilitation Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings